Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Thoracic 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Melanoma 3Colitis 3Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 2Solid Carcinoma 2Lung Neoplasms 2Diarrhea 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Cachexia 1Acute Graft Versus Host Disease 1

Interventions

Loperamide 3Fecal Microbiota Transplantation 2isatuximab 1ceterizine hydrochloride 1capivasertib 1Temozolomide 1Probiotics 1Irinotecan 1Fulvestrant 1Colesevelam Hydrochloride 1Cefixime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diarrhea × Fecal Microbiota Transplantation × 1 year × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT06206707 2025-11-17

Immunobiome

University of Aarhus

Phase NA Recruiting
20 enrolled
DermatologicGenitourinary

Colitis, Diarrhea, Kidney Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡